← Intel Corporation (INTC)

Intel Corporation (INTC) Financials

Q2 FY2026, built from SEC filings. Accession numbers are cited throughout so every figure can be checked against sec.gov. The same data is published as JSON at financials.json for agents that prefer to fetch it directly.

Download financials.json

About this file

Ticker	INTC
CIK	0000050863
Company	Intel Corporation
Business type	industrial
Industry	Semiconductors & related devices (SIC 3674) - integrated design and manufacturing
Reporting currency	USD
Converted to USD	no
Units	actual dollars (not millions); share counts in actual shares; per-share amounts in dollars per share
Fiscal calendar	Intel uses a 52- or 53-week fiscal year ending on the last Saturday in December. Fiscal 2023, 2024 and 2025 were each 52-week years, ending Dec 30, 2023, Dec 28, 2024 and Dec 27, 2025. The second quarter of fiscal 2026 ended June 27, 2026.

Annual

	FY2025	FY2024	FY2023
Fiscal year	2025	2024	2023
Period end	2025-12-27	2024-12-28	2023-12-30
Period type	fiscal_year_52_weeks	fiscal_year_52_weeks	fiscal_year_52_weeks
Source accession	0000050863-26-000011	0000050863-26-000011	0000050863-26-000011
Source form	10-K for the fiscal year ended December 27, 2025	10-K for the fiscal year ended December 27, 2025	10-K for the fiscal year ended December 27, 2025
Income statement
Net revenue	52,853,000,000	53,101,000,000	54,228,000,000
Cost of sales	34,478,000,000	35,756,000,000	32,517,000,000
Gross profit	18,375,000,000	17,345,000,000	21,711,000,000
Gross margin %	34.8%	32.7%	40.0%
Research and development	13,774,000,000	16,546,000,000	16,046,000,000
Marketing general and administrative	4,624,000,000	5,507,000,000	5,634,000,000
Restructuring and other charges	2,191,000,000	6,970,000,000	-62,000,000
Total operating expenses	20,589,000,000	29,023,000,000	21,618,000,000
Operating income loss	-2,214,000,000	-11,678,000,000	93,000,000
Operating margin %	-4.2%	-22.0%	0.2%
Gains losses on equity investments net	514,000,000	242,000,000	40,000,000
Interest and other net	3,257,000,000	226,000,000	629,000,000
Income loss before taxes	1,557,000,000	-11,210,000,000	762,000,000
Provision for benefit from taxes	1,531,000,000	8,023,000,000	-913,000,000
Net income loss including noncontrolling interests	26,000,000	-19,233,000,000	1,675,000,000
Net income loss attributable to noncontrolling interests	293,000,000	-477,000,000	-14,000,000
Net income loss attributable to intel	-267,000,000	-18,756,000,000	1,689,000,000
EPS basic attributable to intel	-0.06	-4.38	0.4
EPS diluted attributable to intel	-0.06	-4.38	0.4
Weighted average shares basic	4,530,000,000	4,280,000,000	4,190,000,000
Weighted average shares diluted	4,530,000,000	4,280,000,000	4,212,000,000
Dividends declared per share	0.0	0.38	0.74
Balance sheet
Cash and cash equivalents	14,265,000,000	8,249,000,000
Short term investments	23,151,000,000	13,813,000,000
Total cash and short term investments	37,416,000,000	22,062,000,000
Accounts receivable net	3,839,000,000	3,478,000,000
Inventories	11,618,000,000	12,198,000,000
Other current assets	10,815,000,000	9,586,000,000
Total current assets	63,688,000,000	47,324,000,000
Property plant and equipment net	105,414,000,000	107,919,000,000
Equity investments	8,512,000,000	5,383,000,000
Goodwill	23,912,000,000	24,693,000,000
Identified intangible assets net	2,772,000,000	3,691,000,000
Other long term assets	7,131,000,000	7,475,000,000
Total assets	211,429,000,000	196,485,000,000
Accounts payable	9,882,000,000	12,556,000,000
Accrued compensation and benefits	3,990,000,000	3,343,000,000
Short term debt	2,499,000,000	3,729,000,000
Income taxes payable	604,000,000	1,756,000,000
Other accrued liabilities	14,600,000,000	14,282,000,000
Total current liabilities	31,575,000,000	35,666,000,000
Long term debt	44,086,000,000	46,282,000,000
Other long term liabilities	9,408,000,000	9,505,000,000
Total liabilities	85,069,000,000	91,453,000,000
Total debt	46,585,000,000	50,011,000,000
Net debt	9,169,000,000	27,949,000,000
Common stock and capital in excess of par	65,185,000,000	50,949,000,000	36,649,000,000
Accumulated other comprehensive income loss	113,000,000	-711,000,000	-215,000,000
Retained earnings	48,983,000,000	49,032,000,000	69,156,000,000
Total intel stockholders equity	114,281,000,000	99,270,000,000	105,590,000,000
Non controlling interests	12,079,000,000	5,762,000,000	4,375,000,000
Total stockholders equity	126,360,000,000	105,032,000,000	109,965,000,000
Shares issued and outstanding	4,994,000,000	4,330,000,000	4,228,000,000
Balance sheet availability			The FY2025 10-K's balance sheet presents only fiscal 2025 and 2024. The equity figures below come from the same 10-K's consolidated statements of stockholders' equity, which carries a fiscal 2023 closing balance; no other fiscal 2023 balance sheet lines are presented in that filing.
Cash flow
Net cash provided by operating activities	9,697,000,000	8,288,000,000	11,471,000,000
Depreciation	10,757,000,000	9,951,000,000	7,847,000,000
Amortization of intangibles	949,000,000	1,428,000,000	1,755,000,000
Share based compensation	2,434,000,000	3,410,000,000	3,229,000,000
Additions to property plant and equipment investing	-14,646,000,000	-23,944,000,000	-25,750,000,000
Additions to property plant and equipment financing	-3,026,000,000	-1,178,000,000	0
Proceeds from capital related government incentives	1,577,000,000	1,936,000,000	1,011,000,000
Net cash used for investing activities	-14,821,000,000	-18,256,000,000	-24,041,000,000
Net cash provided by financing activities	11,587,000,000	11,138,000,000	8,505,000,000
Partner contributions from noncontrolling interest holders	5,108,000,000	12,714,000,000	1,511,000,000
Net proceeds from common stock and warrants issued and escrowed shares	12,706,000,000	0	0
Issuance of long term debt net	0	2,975,000,000	11,391,000,000
Repayment of debt	-3,750,000,000	-2,288,000,000	-423,000,000
Payment of dividends to stockholders	0	-1,599,000,000	-3,088,000,000
Free cash flow	-4,949,000,000	-15,656,000,000	-14,279,000,000
Free cash flow after financing classified capex	-7,975,000,000	-16,834,000,000	-14,279,000,000
Adjusted free cash flow as reported by intel non GAAP	-1,612,000,000	-2,228,000,000	-11,853,000,000
Segments
Client computing group revenue	32,228,000,000	33,346,000,000	32,305,000,000
Client computing group operating income	9,317,000,000	11,594,000,000	10,128,000,000
Data center and ai revenue	16,919,000,000	16,125,000,000	15,980,000,000
Data center and ai operating income	3,422,000,000	1,414,000,000	945,000,000
Intel products total revenue	49,147,000,000	49,471,000,000	48,285,000,000
Intel products total operating income	12,739,000,000	13,008,000,000	11,073,000,000
Intel foundry revenue	17,826,000,000	17,317,000,000	18,504,000,000
Intel foundry operating income loss	-10,318,000,000	-13,291,000,000	-7,083,000,000
All other revenue	3,563,000,000	3,601,000,000	5,463,000,000
All other operating income loss	264,000,000	-57,000,000	1,507,000,000
Corporate unallocated expenses	-5,518,000,000	-11,177,000,000	-5,199,000,000
Intersegment eliminations revenue	-17,683,000,000	-17,288,000,000	-18,024,000,000
Intersegment eliminations operating income	619,000,000	-161,000,000	-205,000,000
Total consolidated revenue	52,853,000,000	53,101,000,000	54,228,000,000
Total consolidated operating income loss	-2,214,000,000	-11,678,000,000	93,000,000
Revenue by customer billing region
United states	15,757,000,000	12,994,000,000	13,958,000,000
China	12,694,000,000	15,532,000,000	14,854,000,000
Singapore	9,535,000,000	10,187,000,000	8,602,000,000
Taiwan	7,672,000,000	7,804,000,000	6,867,000,000
Other regions	7,195,000,000	6,584,000,000	9,947,000,000
Total	52,853,000,000	53,101,000,000	54,228,000,000

Quarterly

	Q2 fiscal 2026 (three months ended June 27, 2026)	Q2 fiscal 2025 (three months ended June 28, 2025) - prior-year comparative	First half of fiscal 2026 (six months ended June 27, 2026)	First half of fiscal 2025 (six months ended June 28, 2025) - prior-year comparative	Trailing twelve months ended June 27, 2026
Label	Q2 fiscal 2026 (three months ended June 27, 2026)	Q2 fiscal 2025 (three months ended June 28, 2025) - prior-year comparative	First half of fiscal 2026 (six months ended June 27, 2026)	First half of fiscal 2025 (six months ended June 28, 2025) - prior-year comparative	Trailing twelve months ended June 27, 2026
Period start	2026-03-29	2025-03-30	2025-12-28	2024-12-29	2025-06-29
Period end	2026-06-27	2025-06-28	2026-06-27	2025-06-28	2026-06-27
Period type	three_months	three_months	six_months	six_months	trailing_twelve_months
Source accession	0000050863-26-000157	0000050863-26-000157	0000050863-26-000157	0000050863-26-000157	0000050863-26-000011 and 0000050863-26-000157
Source form	10-Q for the quarterly period ended June 27, 2026	comparative column in the 10-Q for the quarterly period ended June 27, 2026	10-Q for the quarterly period ended June 27, 2026	comparative column in the 10-Q for the quarterly period ended June 27, 2026
Income statement
Net revenue	16,128,000,000	12,859,000,000	29,705,000,000	25,526,000,000
Cost of sales	9,619,000,000	9,317,000,000	17,849,000,000	17,312,000,000
Gross profit	6,509,000,000	3,542,000,000	11,856,000,000	8,214,000,000
Gross margin %	40.4%	27.5%	39.9%	32.2%
Research and development	3,368,000,000	3,684,000,000	6,743,000,000	7,324,000,000
Marketing general and administrative	1,175,000,000	1,144,000,000	2,213,000,000	2,321,000,000
Restructuring and other charges	170,000,000	1,890,000,000	4,240,000,000	2,046,000,000
Total operating expenses	4,713,000,000	6,718,000,000	13,196,000,000	11,691,000,000
Operating income loss	1,796,000,000	-3,176,000,000	-1,340,000,000	-3,477,000,000
Operating margin %	11.1%	-24.7%	-4.5%	-13.6%
Gains losses on equity investments net	-39,000,000	502,000,000	-111,000,000	390,000,000
Interest and other net	-12,576,000,000	-95,000,000	-13,314,000,000	-268,000,000
Income loss before taxes	-10,819,000,000	-2,769,000,000	-14,765,000,000	-3,355,000,000
Provision for benefit from taxes	29,000,000	255,000,000	364,000,000	556,000,000
Net income loss including noncontrolling interests	-10,848,000,000	-3,024,000,000	-15,129,000,000	-3,911,000,000
Net income loss attributable to noncontrolling interests	185,000,000	-106,000,000	-368,000,000	-172,000,000
Net income loss attributable to intel	-11,033,000,000	-2,918,000,000	-14,761,000,000	-3,739,000,000
EPS basic attributable to intel	-2.16	-0.67	-2.89	-0.86
EPS diluted attributable to intel	-2.16	-0.67	-2.89	-0.86
Weighted average shares basic	5,104,000,000	4,369,000,000	5,108,000,000	4,356,000,000
Weighted average shares diluted	5,104,000,000	4,369,000,000	5,108,000,000	4,356,000,000
Dividends declared per share	0.0	0.0	0.0	0.0
Effective tax rate %	-0.3%	-9.2%	-2.5%	-16.6%
Balance sheet
Cash and cash equivalents	12,874,000,000
Short term investments	16,853,000,000
Total cash and short term investments	29,727,000,000
Accounts receivable net	4,033,000,000
Inventories	12,492,000,000
Other current assets	10,961,000,000
Total current assets	57,213,000,000
Property plant and equipment net	105,741,000,000
Accumulated depreciation on property plant and equipment	109,918,000,000
Equity investments	8,410,000,000
Goodwill	20,465,000,000
Identified intangible assets net	2,545,000,000
Other long term assets	8,065,000,000
Total assets	202,439,000,000
Accounts payable	8,756,000,000
Accrued compensation and benefits	3,748,000,000
Short term debt	1,988,000,000
Other accrued liabilities	21,178,000,000
Total current liabilities	35,670,000,000
Long term debt	48,549,000,000
Other long term liabilities	15,077,000,000
Total liabilities	99,296,000,000
Total debt	50,537,000,000
Net debt	20,810,000,000
Common stock and capital in excess of par	53,780,000,000
Accumulated other comprehensive income loss	-80,000,000
Retained earnings	33,842,000,000
Total intel stockholders equity	87,542,000,000
Non controlling interests	15,601,000,000
Total stockholders equity	103,143,000,000
Shares issued and outstanding	5,043,000,000
Escrowed shares derivative liability	15,570,000,000
Cash flow
Note	Intel's 10-Q presents cash flows only on a six-month (year-to-date) basis; see the six-months-ended June 27, 2026 period below.
Net cash provided by operating activities			8,102,000,000	2,863,000,000
Depreciation			5,891,000,000	5,213,000,000
Amortization of intangibles			469,000,000	474,000,000
Share based compensation			1,307,000,000	1,348,000,000
Additions to property plant and equipment investing			-6,192,000,000	-8,733,000,000
Additions to property plant and equipment financing			-1,423,000,000	-1,962,000,000
Proceeds from capital related government incentives			167,000,000	964,000,000
Acquisitions net of cash acquired			-596,000,000
Net cash used for investing activities			-669,000,000	-2,005,000,000
Net cash used for financing activities			-8,548,000,000
Partner contributions from noncontrolling interest holders			4,082,000,000	2,238,000,000
Partner distributions to noncontrolling interest holders			-14,339,000,000	-91,000,000
Issuance of term debt net			13,000,000,000
Repayment of term debt			-9,000,000,000	-1,500,000,000
Payments on finance leases			-832,000,000	-9,000,000
Payment of dividends to stockholders			0	0
Free cash flow			1,910,000,000	-5,870,000,000
Free cash flow after financing classified capex			487,000,000	-7,832,000,000
Net cash provided by financing activities				586,000,000
Segments
Client computing and physical ai group revenue	8,877,000,000	7,871,000,000	16,604,000,000	15,500,000,000
Client computing and physical ai group operating income	2,343,000,000	2,053,000,000	4,859,000,000	4,414,000,000
Data center and ai revenue	6,262,000,000	3,939,000,000	11,314,000,000	8,065,000,000
Data center and ai operating income	2,474,000,000	633,000,000	4,016,000,000	1,208,000,000
Intel products total revenue	15,139,000,000	11,810,000,000	27,918,000,000	23,565,000,000
Intel products total operating income	4,817,000,000	2,686,000,000	8,875,000,000	5,622,000,000
Intel foundry revenue	5,765,000,000	4,417,000,000	11,186,000,000	9,084,000,000
Intel foundry operating income loss	-2,089,000,000	-3,168,000,000	-4,526,000,000	-5,488,000,000
All other revenue	701,000,000	1,053,000,000	1,329,000,000	1,996,000,000
All other operating income loss	230,000,000	69,000,000	332,000,000	172,000,000
Corporate unallocated expenses	-1,416,000,000	-2,755,000,000	-6,496,000,000	-4,015,000,000
Intersegment eliminations revenue	-5,477,000,000	-4,421,000,000	-10,728,000,000	-9,119,000,000
Intersegment eliminations operating income	254,000,000	-8,000,000	475,000,000	232,000,000
Total consolidated revenue	16,128,000,000	12,859,000,000	29,705,000,000	25,526,000,000
Total consolidated operating income loss	1,796,000,000	-3,176,000,000	-1,340,000,000	-3,477,000,000
Basis					Fiscal 2025 full-year figures from the FY2025 10-K plus the six months ended June 27, 2026 less the six months ended June 28, 2025, both from the Q2 FY2026 10-Q.
Net revenue					57,032,000,000
Gross profit					22,017,000,000
Research and development					13,193,000,000
Operating income loss					-77,000,000
Net income loss including noncontrolling interests					-11,192,000,000
Net income loss attributable to intel					-11,289,000,000
Net cash provided by operating activities					14,936,000,000
Additions to property plant and equipment investing					-12,105,000,000
Free cash flow					2,831,000,000

Units notes seen

	Value
FY2025 10-K consolidated statements of operations	Years Ended (In Millions, Except Per Share Amounts) - the weighted-average basic and diluted share counts in this table are therefore also in millions
FY2025 10-K consolidated statements of comprehensive income (loss)	Years Ended (In Millions)
FY2025 10-K consolidated balance sheets	(In Millions, Except Par Value) - share counts disclosed in the equity captions are in millions
FY2025 10-K consolidated statements of cash flows	Years Ended (In Millions)
FY2025 10-K consolidated statements of stockholders' equity	(In Millions, Except Per Share Amounts) - the 'Number of Shares' column is in millions
FY2025 10-K operating segments note	Year Ended (In Millions)
FY2025 10-K liquidity table (total cash and short-term investments / total debt)	(In Millions)
Q2 FY2026 10-Q consolidated condensed statements of operations	(In Millions, Except Per Share Amounts; Unaudited) - weighted-average share counts in this table are in millions
Q2 FY2026 10-Q consolidated condensed balance sheets	(In Millions; Unaudited) - issued and outstanding share counts in the equity captions are in millions
Q2 FY2026 10-Q consolidated condensed statements of cash flows	(In Millions; Unaudited)
Q2 FY2026 10-Q operating segments note	(In Millions)
Q2 FY2026 10-Q liquidity table (total cash and short-term investments / total debt)	(In Millions)

Adjustments

	Value
Splits applied	none
Splits note	No stock splits are on record for Intel over the periods reported, so no split adjustment was required; the earnings-per-share and share counts below are exactly as the filings present them.
ADR ratio	n/a
ADR note	Intel common stock trades directly on Nasdaq; it is not an ADR, so no ADR-ratio conversion applies.
FX	None. Intel reports in U.S. dollars, so no currency conversion was applied.

Notes

Template: the standard operating-company (industrial) template - revenue, cost of sales, gross profit, R&D, MG&A, restructuring, operating income, net income split between Intel and non-controlling interests, diluted EPS and share counts; cash and short-term investments, total debt, total assets and equity; operating cash flow, capital expenditures and free cash flow. Intel is an integrated semiconductor designer and manufacturer, so that template fits, and it is extended with the operating-segment revenue and operating income split (Intel Products, made up of the client and data-center segments, versus Intel Foundry) plus revenue by customer billing region, because Intel's economics are unintelligible without seeing that the products business is profitable while the foundry business loses money.
Reported dollar amounts are stated in this file in actual dollars. Every statement in both filings is scaled in millions and every share count in those statements is likewise in millions; the figures below have been multiplied out accordingly.
Annual coverage: the FY2025 10-K (accession 0000050863-26-000011) presents three years of income statement and cash flow (fiscal 2025, 2024 and 2023) but only two balance sheet dates (December 27, 2025 and December 28, 2024). Fiscal 2023 therefore has no balance sheet here beyond the closing equity balances, which that 10-K's statement of stockholders' equity does present.
Quarterly coverage: the Q2 FY2026 10-Q (accession 0000050863-26-000157) presents the three and six months ended June 27, 2026 with prior-year comparatives, and cash flows on a six-month basis only. No standalone three-month cash flow statement exists, so none is shown. Intel also issued a Q2 2026 earnings release on July 23, 2026 covering the same quarter; the figures here are taken from the 10-Q, which is the audited-basis filing of record for the period.
Free cash flow as defined in this file is net cash provided by operating activities less 'Additions to property, plant and equipment' as reported within investing activities. Intel also reports a second line of property, plant and equipment additions inside financing activities (capital purchases made on extended payment terms): $3.0 billion in fiscal 2025, $1.2 billion in fiscal 2024, $1.4 billion in the first half of fiscal 2026 and $2.0 billion in the first half of fiscal 2025. 'free_cash_flow_after_financing_classified_capex' subtracts that second line as well, and is the more conservative measure of what capital spending actually cost in cash.
'adjusted_free_cash_flow_as_reported_by_intel_non_gaap' is Intel's own non-GAAP measure as reconciled in the FY2025 10-K. It starts from operating cash flow and subtracts capital expenditures net of capital-related government incentives and net partner contributions from the semiconductor co-investment programs, and also subtracts finance lease payments. It is not comparable to the free cash flow figures computed above and is included only because Intel presents it.
Non-controlling interests are material to Intel and the two profit lines diverge. In fiscal 2025 consolidated net income was a positive $26 million, but $293 million of that belonged to minority partners in the Arizona and Ireland semiconductor co-investment programs, Mobileye and IMS Nanofabrication, leaving a $267 million loss attributable to Intel. Earnings per share is always computed on the amount attributable to Intel.
Intel paid no dividends in fiscal 2025 or in the first half of fiscal 2026. The dividend was cut to $0.125 per quarter in 2024 and then suspended; dividends declared were $0.38 per share in fiscal 2024 and $0.74 per share in fiscal 2023.
Fiscal 2025 income before taxes of $1.6 billion was carried almost entirely by items below the operating line: 'Interest and other, net' of $3.3 billion, which included a $5.3 billion gain on divestitures (chiefly the September 2025 sale of 51% of Altera) offset by a $1.8 billion mark-to-market loss on shares held in escrow for the U.S. government. Operating income itself was a loss of $2.2 billion.
The Q2 fiscal 2026 headline loss is dominated by a single non-operating, non-cash item. Operating income was a positive $1.8 billion - Intel's first positive quarterly operating income in this series - but 'Interest and other, net' was a negative $12.6 billion because of a $12.5 billion loss on the change in fair value of the derivative liability for Escrowed Shares issued to the U.S. Department of Commerce under the CHIPS Act Secure Enclave agreement. The liability is measured against the value of Intel common stock and rises as that value rises. Its carrying value was $15.6 billion at June 27, 2026 against $2.7 billion at December 27, 2025, split between other accrued liabilities and other long-term liabilities. For the first half the corresponding loss was $13.6 billion.
The first half of fiscal 2026 also includes $4.2 billion of restructuring and other charges, of which $3.9 billion is a non-cash goodwill impairment recognised in the first quarter, substantially all of it against the Mobileye reporting unit following an increase in the discount rate used in the impairment test. Mobileye's recorded goodwill fell to $4.3 billion at June 27, 2026 from $8.2 billion at December 27, 2025, which is the main reason consolidated goodwill fell from $23.9 billion to $20.5 billion.
In the second quarter of fiscal 2026 Intel bought out the 49% minority interest in the Ireland semiconductor co-investment program for $14.2 billion in cash, funded from existing cash and short-term investments plus a $6.5 billion term loan that was then repaid with $6.5 billion of new senior notes. This is why financing activities show a $14.3 billion partner distribution, $13.0 billion of term-debt issuance and $9.0 billion of repayment in the six-month period, and why total debt rose from $46.6 billion to $50.5 billion while total cash and short-term investments fell from $37.4 billion to $29.7 billion.
Total debt is stated as short-term debt plus long-term debt and agrees with the liquidity tables in both filings: $50.5 billion at June 27, 2026, $46.6 billion at December 27, 2025 and $50.0 billion at December 28, 2024.
Segment labels changed between the two filings. The client segment was renamed from Client Computing Group (CCG) in the FY2025 10-K to Client Computing and Physical AI Group (CCPG) in the Q2 FY2026 10-Q; it is the same segment and the field names here follow the filing each figure came from. Separately, Intel recast prior-period segment operating results in the second quarter of 2025 to reflect the expense detail its chief operating decision maker now reviews, and the fiscal 2024 and 2023 segment figures shown here are the recast versions as presented in the FY2025 10-K.
Intel Foundry's revenue is overwhelmingly intersegment - wafer, substrate and related sales to Intel Products - which is why the intersegment eliminations line is large and negative. Only $307 million of Intel Foundry's fiscal 2025 revenue came from external customers ($159 million in fiscal 2024, $547 million in fiscal 2023).
The divestiture of 51% of Altera closed on September 12, 2025. Altera's results were reported inside the 'all other' category for all periods through September 11, 2025 and are excluded thereafter, which explains the drop in 'all other' revenue from $1.1 billion in Q2 fiscal 2025 to $0.7 billion in Q2 fiscal 2026.
Because Intel recorded net losses in every quarterly period shown, potentially dilutive securities were anti-dilutive and excluded, so basic and diluted share counts and earnings per share are identical in those periods. In Q2 fiscal 2026, 70 million such shares were excluded (67 million for the six months).
Every figure in this file was read from the face of the FY2025 10-K or the Q2 FY2026 10-Q. Where checked against the SEC's XBRL company facts for the same concepts - revenue, operating income, net income, earnings per share, diluted shares, total assets, stockholders' equity, operating cash flow, capital expenditures and cash - the structured data agreed with the filings in every case, so no conflicts had to be resolved.

Uncertainties

Fiscal 2025 earnings per share of negative $0.06 is a rounding-sensitive figure: a $267 million loss attributable to Intel across 4,530 million weighted-average shares. The 10-K reports it as negative $0.06 and that is what is carried here, but any ratio derived from it will be imprecise.
Total liabilities is not presented as a subtotal on Intel's balance sheet. The figure here is the sum of total current liabilities, long-term debt and other long-term liabilities, which reconciles to total assets less total stockholders' equity at each date.
Fiscal 2023 has no balance sheet in the FY2025 10-K. Only the closing equity balances are shown, taken from that filing's statement of stockholders' equity. Total assets, cash, debt and working-capital lines for fiscal 2023 are simply not available from the filings covered here.
No three-month cash flow statement exists for Q2 fiscal 2026; Intel presents cash flows only year-to-date. Any quarterly free cash flow figure would have to be inferred by subtraction from a first-quarter filing, and is not attempted here.
The Escrowed Shares derivative liability is a fair-value estimate that moves with the value of Intel common stock, and the $12.5 billion second-quarter charge is the single largest driver of the reported loss. It is reported exactly as filed, but it is a mark-to-market estimate rather than a settled amount, and it would reverse in part if that value declined.
Intel discloses approximately $1.0 billion accrued at June 27, 2026 for the VLSI patent litigation and states it cannot estimate losses in excess of recorded amounts across several other matters, including claims where alleged damages exceed $2.0 billion. Those contingencies are not reflected in the balance sheet figures beyond the amount already accrued.
The trailing-twelve-month block is arithmetic performed here by combining the fiscal 2025 full year with the two half-year periods in the 10-Q. It is not a figure Intel reports, and the underlying periods span the Altera divestiture, so the revenue and margin it implies are not on a fully like-for-like basis.

Company details

	Value
Name	Intel Corp
Ticker	INTC
CIK	0000050863
Exchange	Nasdaq
State	California
Incorporation	Delaware
SIC	3674
Office	Manufacturing
Industry	Semiconductors & Related Devices

Next filing

	Value
Predicted date	2026-08-07
Predicted type	10-Q

Fiscal period

	FY2026
Fiscal year	2026
Fiscal period	Q2
Tag	FY26Q2
Period end	2026-06-27
Form	10-Q
Accession	0000050863-26-000157
Fiscal year end	1227
Source	facts

Built from Intel Corporation's SEC filings by Ticker Scout. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer. Also for this company: company index, financials.json, index.json.